Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Probasco

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
The Neurohospitalist|October 2, 2015
Facilitating Early-In-Day Discharge for Multiple Sclerosis Patients Treated With Intravenous Methylprednisolone: A Quality Improvement ProjectJohn C Probasco, Gina Hawley, Margie Burnett, et al.
The Neurohospitalist|April 7, 2018
Choosing Wisely Together: Physical and Occupational Therapy Consultation for Acute Neurology InpatientsJohn C Probasco, Annette Lavezza, Andre Cassell, et al.
JAMA Neurology|June 9, 2016
Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic CancerTanya J Williams, David R Benavides, Kelly-Ann Patrice, et al.
Neurology|January 24, 2014
Ketogenic diet for adults in super-refractory status epilepticusKiran T Thakur, John C Probasco, Sara E Hocker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2020
MOG-IgG1 and co-existence of neuronal autoantibodiesAmy Kunchok, Eoin P Flanagan, Karl N Krecke, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 24, 2022
Visual Pathway Involvement in NMDA Receptor Encephalitis: A Clinical, Optical Coherence Tomography, and 18-Fluorodeoxyglucose PET/CT ApproachGrigorios Kalaitzidis, Angeliki Filippatou, Nicholas Fioravante, et al.
Neurology|November 14, 2024
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic IndicationsCarson M Quinn, Prashanth Rajarajan, Alexander J Gill, et al.
Neurology|February 10, 2017
Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticusMackenzie C Cervenka, Sara Hocker, Matthew Koenig, et al.
Neurology|August 23, 2015
New-onset refractory status epilepticus: Etiology, clinical features, and outcomeNicolas Gaspard, Brandon P Foreman, Vincent Alvarez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse EventsJarushka Naidoo, Jiajia Zhang, Evan J Lipson, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
The Neurohospitalist|October 2, 2015
Facilitating Early-In-Day Discharge for Multiple Sclerosis Patients Treated With Intravenous Methylprednisolone: A Quality Improvement ProjectJohn C Probasco, Gina Hawley, Margie Burnett, et al.
The Neurohospitalist|April 7, 2018
Choosing Wisely Together: Physical and Occupational Therapy Consultation for Acute Neurology InpatientsJohn C Probasco, Annette Lavezza, Andre Cassell, et al.
JAMA Neurology|June 9, 2016
Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic CancerTanya J Williams, David R Benavides, Kelly-Ann Patrice, et al.
Neurology|January 24, 2014
Ketogenic diet for adults in super-refractory status epilepticusKiran T Thakur, John C Probasco, Sara E Hocker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2020
MOG-IgG1 and co-existence of neuronal autoantibodiesAmy Kunchok, Eoin P Flanagan, Karl N Krecke, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 24, 2022
Visual Pathway Involvement in NMDA Receptor Encephalitis: A Clinical, Optical Coherence Tomography, and 18-Fluorodeoxyglucose PET/CT ApproachGrigorios Kalaitzidis, Angeliki Filippatou, Nicholas Fioravante, et al.
Neurology|November 14, 2024
Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic IndicationsCarson M Quinn, Prashanth Rajarajan, Alexander J Gill, et al.
Neurology|February 10, 2017
Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticusMackenzie C Cervenka, Sara Hocker, Matthew Koenig, et al.
Neurology|August 23, 2015
New-onset refractory status epilepticus: Etiology, clinical features, and outcomeNicolas Gaspard, Brandon P Foreman, Vincent Alvarez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse EventsJarushka Naidoo, Jiajia Zhang, Evan J Lipson, et al.
Pageof 7